Skip to content

NA - NA

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2019-002544-24-FR
Enrollment
81
Registered
2019-11-27
Start date
2020-01-16
Completion date
Unknown
Last updated
2020-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Chlorure de Potassium 10 % - 2 g /20 ml - solution à diluer pour perfusion Product Name: Chlorure de potassium 10 %, solution pour perfusion Pharmaceutical

Sponsors

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Lead Sponsor
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 51

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Main Objective: NA;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA

Secondary

MeasureTime frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA

Countries

France

Contacts

Public ContactDRCI

ASSISTANCE-PUBLIQUE-HOPITAUX DE PARIS

sylvie.prieur@aphp.fr

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 9, 2026